Tirzepatide Dosage: Starting Dose, Titration, and Units Explained

Tirzepatide's FDA-approved dosage starts at 2.5 mg injected once weekly, then increases in 2.5 mg increments no sooner than every four weeks, up to a maximum of 15 mg per week. Mounjaro and Zepbound, the two brand-name versions approved in the United States, follow that same ladder. Compounded tirzepatide uses the same milligram targets, but the number of units you draw depends entirely on the concentration of your vial.

This guide covers the standard tirzepatide dosing schedule, how to convert milligrams to units on a U-100 syringe, what compounded vial labels actually mean, and where microdosing fits, or does not fit, into approved care.

FDA-Approved Tirzepatide Dosing Schedule

Tirzepatide is titrated slowly to reduce gastrointestinal side effects. The 2.5 mg starting dose is a tolerance-building step, not a therapeutic weight-loss dose, and the label explicitly does not list it as a maintenance dose. Most people move up only after at least four weeks at their current level and only if the medication is being tolerated.

Weeks	Weekly dose	Role in treatment
1 to 4	2.5 mg	Starting dose, not for ongoing therapy
5 to 8	5 mg	First maintenance-level dose
9 to 12	7.5 mg	Optional step up
13 to 16	10 mg	Approved maintenance dose
17 to 20	12.5 mg	Approved maintenance dose
21 and beyond	15 mg	Maximum approved dose

Not everyone climbs the full ladder. Many patients stay at 5 mg, 7.5 mg, or 10 mg if appetite control and weight loss are adequate. The highest FDA-approved dose of tirzepatide is 15 mg once weekly, and doses above 15 mg are not supported by clinical trial data.

Tirzepatide's approved starting dose is 2.5 mg once weekly for four weeks, and the maximum approved dose is 15 mg once weekly. Titration steps should be spaced at least four weeks apart.

Tirzepatide Dosing in Units: Why Concentration Matters

Most U.S. insulin syringes are marked in units, and 100 units equals 1 mL. That is why the question "how many units is 2.5 mg of tirzepatide" has no single answer: it depends on how many milligrams sit in each milliliter of your vial. The conversion is straightforward: units = (dose in mg ÷ concentration in mg/mL) × 100.

Dose (mg)	Units at 10 mg/mL	Units at 20 mg/mL
2.5 mg	25 units	12.5 units
5 mg	50 units	25 units
7.5 mg	75 units	37.5 units
10 mg	100 units	50 units
12.5 mg	125 units	62.5 units
15 mg	150 units	75 units

A 15 mg dose at 10 mg/mL requires 150 units, or 1.5 mL, which is more than a standard 1 mL syringe holds. That is one reason pharmacies often dispense higher-concentration vials as doses increase. Online tirzepatide dosage calculators can double-check your math, but they are only as accurate as the numbers you enter.

Compounded Tirzepatide Dosage Charts and Vial Sizes

Compounded tirzepatide is not FDA-approved, and pharmacies mix it at different strengths. A 30 mg/3 mL vial is 10 mg/mL. A 60 mg/3 mL vial is 20 mg/mL. A 40 mg vial could be 20 mg/mL (40 mg in 2 mL) or 10 mg/mL (40 mg in 4 mL), so the label is the only reliable source.

A compounded tirzepatide dosing chart is only accurate for the exact concentration printed on the vial it came with. Never borrow another patient's chart, because concentrations differ between pharmacies and sometimes between refills.

Some people also research unrelated peptides alongside their medication, and searches such as aod 9604 and tirzepatide together side effects or cagrilintide vs tirzepatide show up in the same forums. Those are separate compounds with separate safety profiles, and there is no FDA-approved product that combines them with tirzepatide. Research-oriented references, including an aod 9604 dosage protocol or a kisspeptin-10 dosage guide, describe laboratory materials that are not approved for human use.

Microdosing Tirzepatide and Maintenance Doses

Microdosing tirzepatide usually means using doses below the approved 2.5 mg starting dose, or splitting a weekly dose into smaller, more frequent injections. It is not an FDA-approved dosing strategy and has not been evaluated in randomized controlled trials.

After reaching a weight-loss goal, many patients shift to a tirzepatide maintenance dose, which is often the lowest dose that keeps appetite and weight stable. Some clinicians lower the strength gradually instead of stopping abruptly, because appetite can return quickly after the last injection.

There is no validated microdosing tirzepatide chart. Any schedule circulating online reflects one person's personal protocol, not clinical evidence, and a microdose still carries the same boxed warning as a full dose.

How to Calculate and Confirm Your Tirzepatide Dose

1. Read the concentration on the vial label, for example 20 mg/mL.
2. Confirm the prescribed dose in milligrams with your prescriber.
3. Apply the formula: (mg ÷ mg per mL) × 100 = units.
4. Check that the calculated volume fits your syringe size.
5. Ask a pharmacist to verify the calculation before your first injection.

Dose changes should come from your prescriber, not from a chart you found online. If a refill arrives at a different concentration than before, recalculate before drawing up your usual number of units.

Safety, Side Effects, and When to Call a Clinician

• Nausea, vomiting, diarrhea, and constipation are the most common side effects, especially in the days after a dose increase.
• Tirzepatide carries a boxed warning for thyroid C-cell tumors and is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN2.
• Contact a clinician for severe or persistent abdominal pain, signs of gallbladder disease, or vision changes.
• Pregnancy, breastfeeding, a history of pancreatitis, and kidney disease all require individualized medical input.

Dosing decisions belong with a licensed healthcare professional who knows your history. This article is general information and is not a substitute for personalized medical advice.

COMMON QUESTIONS

Frequently Asked Questions

What is the starting dose of tirzepatide?

The FDA-approved starting dose of tirzepatide is 2.5 mg injected once weekly for four weeks. It is intended to build tolerance rather than to drive weight loss, and the label does not list 2.5 mg as a maintenance dose. After four weeks, most patients move to 5 mg weekly if the medication is tolerated.

How many units is 2.5 mg of tirzepatide?

It depends on the concentration of your vial. At 10 mg/mL, 2.5 mg equals 25 units on a U-100 syringe; at 20 mg/mL, 2.5 mg equals 12.5 units. Always confirm the concentration on the label and have a pharmacist verify the conversion before injecting.

What is the highest dose of tirzepatide?

The maximum FDA-approved tirzepatide dose is 15 mg once weekly. Doses above 15 mg are not supported by clinical trial data and are not part of the approved labeling for Mounjaro or Zepbound. Many patients never need to reach 15 mg and stay at a lower maintenance dose.